IRadimed Corporation Financial Ratios — IRMD Stock

Profitability (USD)

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	91.92	50	84.69	44.36	2.48	26.81	30.59	3.7	22.03	27.22	37.98	38.45	37.15
Return on Assets (%)	- -	30.89	13.54	25.72	19.92	1.31	14.42	16.72	1.99	12.12	15.24	19.35	20.2	21.71
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	40.86	15.8	28.19	22.45	1.41	- -	- -	- -	13.4	16.46	21.23	21.73	22.66
Gross Margin (%)	72.34	74.84	78.25	81.51	81.06	75.87	76.31	77.11	74.33	76.65	77.45	76.5	76.94	76.75
EBITDA Margin (%)	19.92	25.8	20.54	39	36.54	11.24	23.35	25.68	1.84	26.84	30.58	31.73	31.11	32.59
Operating Margin (%)	18.54	24.58	19.59	36.44	33.6	5.57	19.72	22.45	-2.38	23.48	29.32	30.56	29.99	31.2
Incremental Operating Margin (%)	- -	37.28	6.46	52.99	-65.69	102.34	64.14	32.73	- -	104.72	50.57	35.96	25.13	39.56
Pretax Margin (%)	18.63	24.55	19.28	36.83	33.7	6.05	20.36	23.48	-1.94	23.52	30.36	33.16	33.14	33.84
Profit Margin (%)	12.57	17.08	13.1	23.83	22.2	2.17	20.71	25	4.32	22.3	24.07	26.22	26.26	26.82
Net Income to Common Margin (%)	12.57	17.08	13.1	23.83	22.2	2.17	20.71	25	4.32	22.3	24.07	26.22	26.26	26.82
Effective Tax Rate (%)	32.54	30.42	32.05	35.28	34.13	64.21	- -	- -	- -	5.19	20.72	20.91	20.77	20.74
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	97.9	76.91	71.11	66.9
Sustainable Growth Rate (%)	- -	91.92	50	84.69	44.36	2.48	26.81	30.59	3.7	22.03	0.57	8.77	11.11	12.3

Credit (USD)

API Chat

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	1	- -	- -	- -	- -	- -	- -	3	3	2	2	2	- -	- -
ST Debt	1	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
LT Debt	- -	- -	- -	- -	- -	- -	- -	3	2	2	2	2	- -	- -
Total Debt/EBITDA	0.34	- -	- -	- -	- -	- -	- -	0.3	4.66	0.22	0.14	0.1	0.01	- -
Net Debt/EBITDA	-0.77	-0.84	-2.94	-1.57	-1.49	-7.02	-3.94	-4.4	-85.92	-5.52	-3.56	-2.39	-2.29	-1.87
Total Debt/EBIT	0.36	- -	- -	- -	- -	- -	- -	0.34	-3.59	0.25	0.14	0.1	0.01	- -
Net Debt/EBIT	-0.83	-0.88	-3.08	-1.68	-1.62	-14.17	-4.67	-5.03	66.22	-6.32	-3.71	-2.48	-2.38	-1.96
EBITDA to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBIT to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	20.5	44.02	21.99	35.91	53.42	52.18	55.06	54.4	53.01	56.7	55.27	46.94	57.76	59.05
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	4.89	4.01	3.06	2.6	2.26	- -	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	6.92	6.09	4.46	3.86	3.57	- -	- -
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	4.07	3.46	2.66	2.24	1.75	- -	- -
Total Debt/Equity (%)	16.14	0.12	- -	- -	- -	- -	- -	5.32	4.42	3.44	2.99	2.86	0.18	- -
Total Debt/Capital (%)	31.34	0.21	- -	- -	- -	- -	- -	7.53	6.72	5.02	4.46	4.51	0.27	- -
Total Debt/Total Assets (%)	9.36	0.09	- -	- -	- -	- -	- -	4.43	3.82	2.99	2.58	2.22	0.16	- -
Net Debt to Equity	-36.57	-45.28	-45.26	-60.65	-55.55	-55.29	-66.82	-78.31	-81.57	-85.9	-78.67	-69.68	-60.16	-54.07
Net Debt/Capital (%)	3,039.45	-395.69	218.45	288.57	-821.26	-846.54	2,065.27	1,029.33	517.08	495.15	682.69	1,115.81	-1,108.23	-391.33
EBITDA	2	3	3	12	12	3	7	10	1	11	16	21	23	27
EBITDA-CapEx	1	3	3	12	10	2	7	9	- -	11	15	13	15	20
Operating Income (Loss)	1	3	3	12	11	1	6	9	-1	10	16	20	22	26

Liquidity (USD)

API Chat

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	0.84	1.86	7.63	9.34	7.01	6.46	7.33	7.89	10.57	9.16	6.78	3.05	6.14	5.03
Current Ratio	2.14	4.4	9.74	11.76	9.25	8.61	9.5	10.06	12.96	11.18	9.06	4.65	8.84	7.98
Quick Ratio	1.52	3.23	8.49	10.68	8.04	7.39	8.23	9.14	11.5	9.91	8.33	3.8	7.38	6.37
CFO/Avg Current Liab	- -	0.78	1.39	2.96	2.87	0.88	1.68	1.94	1.08	1.92	1.31	1.08	2.06	2.67
Common Equity/Total Assets	20.5	44.02	21.99	35.91	53.42	52.18	55.06	54.4	53.01	56.7	55.27	46.94	57.76	59.05
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	4.89	4.01	3.06	2.6	2.26	- -	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	6.92	6.09	4.46	3.86	3.57	- -	- -
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	4.07	3.46	2.66	2.24	1.75	- -	- -
Total Debt/Equity (%)	16.14	0.12	- -	- -	- -	- -	- -	5.32	4.42	3.44	2.99	2.86	0.18	- -
Total Debt/Capital (%)	31.34	0.21	- -	- -	- -	- -	- -	7.53	6.72	5.02	4.46	4.51	0.27	- -
Total Debt/Total Assets (%)	9.36	0.09	- -	- -	- -	- -	- -	4.43	3.82	2.99	2.58	2.22	0.16	- -
CFO/Total Liabilities	64.66	94.27	106.89	231.02	177.3	56.17	113.54	91.33	60.09	105.14	84.81	64.94	222.68	176.2
CFO/CapEx	9.34	7.69	4.26	24.3	6.17	4.14	27.87	21.06	13.13	23.34	12.2	1.81	3.2	3.21
Altman's Z-Score	3.25	4.58	30.44	59.44	17.24	18.34	27.15	16.88	19.31	34.7	21.05	20.25	39.54	55.72

Working Capital (USD)

API Chat

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	- -	6.36	7.94	10.85	8.51	6.11	7.62	6.7	5.34	8.61	5.79	5.14	6.43	6.92
Days Sales Outstanding	- -	57.41	45.96	33.64	42.9	59.73	47.9	54.5	68.29	42.39	63.04	70.98	56.76	52.74
Inventory Turnover	- -	2.09	1.96	2.59	1.96	1.38	1.74	2.29	2.15	2.37	2.49	1.69	1.45	1.77
Days Inventory Outstanding	- -	174.37	185.81	140.9	185.91	265.32	209.29	159.42	169.78	153.89	146.8	215.51	250.9	206.21
Accounts Payable Turnover	- -	6.72	7.93	7.46	7.2	6.63	9.88	9.51	10.22	14.07	10.14	12.5	7.71	11.15
Accounts Payable Turnover Days	- -	54.33	46.02	48.92	50.67	55.04	36.94	38.38	35.72	25.94	36	29.2	47.33	32.75
Cash Conversion Cycle	- -	177.45	185.75	125.61	178.14	270.01	220.25	175.54	202.36	170.33	173.83	257.3	260.34	226.2
Inventory to Cash Days	- -	-116.96	-139.85	-107.26	-143	-205.58	-161.39	-104.91	-101.49	-111.5	-83.76	-144.53	-194.14	-153.46
Inventories	1	1	2	2	4	4	4	4	4	4	5	13	10	12
Raw Materials	1	1	2	2	3	4	3	3	3	4	5	11	9	10
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	1	1
Finished Goods	- -	- -	- -	- -	1	1	1	1	1	1	- -	2	1	2
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	- -	- -	113	308	120	161	263	264	276	571	355	598	697	1,238
- Cash & Cash Equivalents	2	2	9	19	18	18	28	43	50	62	58	50	52	51
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	1	- -	- -	- -	- -	- -	- -	3	3	2	2	2	- -	- -
Enterprise Value	-1	-3	95	281	94	135	229	220	227	510	300	551	645	1,186
Total Capital	2	3	5	13	20	20	27	39	40	49	49	45	57	64
Total Debt/Capital (%)	31.34	0.21	- -	- -	- -	- -	- -	7.53	6.72	5.02	4.46	4.51	0.27	- -
Total Debt / EV	-0.36	- -	- -	- -	- -	- -	- -	0.01	0.01	- -	0.01	- -	- -	- -
EV/Sales	- -	- -	6.1	8.91	2.91	5.84	7.52	5.72	7.16	12.21	5.62	8.4	8.8	14.16
EV/EBITDA	- -	- -	29.68	22.84	7.95	51.99	32.18	22.29	389.81	45.48	18.39	26.47	28.3	43.44
EV/EBIT	- -	- -	31.12	24.45	8.65	104.93	38.11	25.5	- -	52	19.17	27.48	29.36	45.38
EV/Cash Flow to Firm	- -	- -	36.9	36.79	10.04	39.47	31.02	21.55	39.05	45.34	29.84	40.89	25.16	47.56
EV/Free Cash Flow to Firm	- -	- -	29.89	35.34	8.64	31.8	29.94	20.57	36.28	43.48	27.58	26.33	19.17	36.27
Diluted Market Cap	- -	- -	132	352	133	178	296	287	284	582	357	604	703	1,250
Diluted Enterprise Value	-1	-2	122	333	115	159	268	246	236	522	302	556	651	1,199
EV per Share	- -	- -	10.91	25.58	8.73	12.67	21.26	19.54	18.74	41.35	23.85	43.68	50.89	93.26
TTM Sales	8	11	16	32	32	23	30	39	32	42	53	66	73	84
TTM EBITDA	2	3	3	12	12	3	7	10	1	11	16	21	23	27
TTM Operating Income	1	3	3	12	11	1	6	9	-1	10	16	20	22	26
TTM Cash Flow to Firm	2	1	3	8	9	3	7	10	6	11	10	13	26	25
TTM Free Cash Flow to Firm	2	2	3	8	11	4	8	11	6	12	11	21	34	33

Multiples (USD)

API Chat

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	- -	- -	41.3	44.19	12.18	41.87	38.77	26.78	45.31	49.56	32.9	28.89	20.91	38.23
EV/EBIT	- -	- -	31.12	24.45	8.65	104.93	38.11	25.5	- -	52	19.17	27.48	29.36	45.38
Enterprise Value	-1	-3	95	281	94	135	229	220	227	510	300	551	645	1,186
Low Price	- -	- -	6.26	12.72	8.95	7.85	12.51	16.68	14.42	21.65	26	27.87	40.18	47.48
EV/Sales	- -	- -	6.1	8.91	2.91	5.84	7.52	5.72	7.16	12.21	5.62	8.4	8.8	14.16
EV/EBITDA	- -	- -	29.68	22.84	7.95	51.99	32.18	22.29	389.81	45.48	18.39	26.47	28.3	43.44
Price/Earnings	- -	- -	55.01	40.96	16.64	322.51	41.75	27.39	201.91	61.18	27.7	34.8	36.23	55.05
Price/Earnings Average	- -	- -	37.63	31.27	24.89	212.9	36.67	27.34	201.09	41.78	35.59	31.15	30.57	37.41
Price/Earnings High	- -	- -	58	48.59	41.99	335.28	66.19	34.91	251.77	64.54	54.76	37.41	38.17	55.76
Price/Earnings Low	- -	- -	26.69	18.59	13.42	167.11	21.35	19.54	127.7	28.66	25.46	20.43	26.47	26.87
Price/Book Value	- -	- -	22	24.37	6.04	7.92	9.87	7.27	7.34	12.14	7.52	13.83	12.27	19.27
Price/Book Value Average	- -	- -	15.05	18.6	9.04	5.23	8.67	7.25	7.31	8.29	9.66	12.38	10.35	13.09
Price/Book Value High	- -	- -	23.2	28.91	15.24	8.23	15.64	9.26	9.15	12.81	14.86	14.87	12.93	19.52
Price/Book Value Low	- -	- -	10.68	11.06	4.87	4.1	5.05	5.18	4.64	5.69	6.91	8.12	8.96	9.4
Price/Tangible Book Value	- -	- -	5.46	9.72	3.88	5.03	6.4	4.83	4.57	8.03	4.96	8.68	8.32	13.57
Price/Tangible Book Value Average	- -	- -	3.74	7.42	5.8	3.32	5.62	4.82	4.56	5.48	6.38	7.77	7.02	9.22
Price/Tangible Book Value High	- -	- -	5.76	11.53	9.78	5.23	10.15	6.15	5.7	8.47	9.81	9.34	8.77	13.74
Price/Tangible Book Value Low	- -	- -	2.65	4.41	3.13	2.61	3.27	3.44	2.89	3.76	4.56	5.1	6.08	6.62
Price/Sales	- -	- -	7.21	9.76	3.7	6.98	8.65	6.85	8.72	13.64	6.67	9.13	9.51	14.77
Price/Sales Average	- -	- -	4.93	7.45	5.52	4.61	7.59	6.84	8.68	9.32	8.56	8.17	8.03	10.03
Price/Sales High	- -	- -	7.6	11.58	9.32	7.26	13.71	8.73	10.87	14.39	13.18	9.81	10.02	14.96
Price/Sales Low	- -	- -	3.5	4.43	2.98	3.62	4.42	4.89	5.51	6.39	6.13	5.36	6.95	7.21
Price/Cash Flow	- -	- -	43.62	40.32	12.77	47.18	35.68	25.78	47.51	50.68	35.39	44.43	27.2	49.61
Price/Cash Flow Average	- -	- -	29.84	30.78	19.09	31.15	31.34	25.74	47.32	34.6	45.46	39.78	22.95	33.71
Price/Cash Flow High	- -	- -	45.99	47.83	32.2	49.05	56.57	32.86	59.25	53.46	69.95	47.77	28.65	50.25
Price/Cash Flow Low	- -	- -	21.17	18.3	10.29	24.45	18.25	18.39	30.05	23.74	32.52	26.09	19.87	24.21
Price/Free Cash Flow Average	- -	- -	28.25	33.74	18.2	27.64	34.05	26.73	45.12	33.84	42.26	25.86	17.64	25.97
Price/Free Cash Flow High	- -	- -	43.54	52.42	30.71	43.53	61.46	34.13	56.49	52.28	65.03	31.06	22.03	38.72
Price/Free Cash Flow Low	- -	- -	20.04	20.06	9.82	21.7	19.83	19.1	28.65	23.22	30.24	16.96	15.27	18.66
EV/Sales Average	- -	- -	4.33	6.84	4.98	3.82	6.67	5.79	7.19	7.89	7.52	7.44	7.32	9.42
EV/Sales High	- -	- -	6.99	10.97	8.78	6.47	12.79	7.68	9.37	12.97	12.13	9.08	9.31	14.35
EV/Sales Low	- -	- -	2.89	3.82	2.43	2.83	3.5	3.83	4.02	4.97	5.08	4.63	6.24	6.6
EV/EBITDA Average	-0.77	-0.84	21.06	17.54	13.63	34	28.57	22.53	391.17	29.41	24.59	23.46	23.53	28.91
EV/EBITDA High	-0.77	-0.84	34.05	28.12	24.02	57.58	54.75	29.9	510.21	48.32	39.68	28.63	29.94	44.02
EV/EBITDA Low	-0.77	-0.84	14.08	9.79	6.66	25.18	14.99	14.93	218.74	18.51	16.62	14.59	20.06	20.24
EV/EBIT Average	-0.83	-0.88	22.08	18.77	14.82	68.63	33.83	25.77	-301.48	33.62	25.64	24.35	24.4	30.2
EV/EBIT High	-0.83	-0.88	35.7	30.1	26.12	116.23	64.83	34.19	-393.23	55.24	41.39	29.72	31.06	45.98
EV/EBIT Low	-0.83	-0.88	14.77	10.47	7.24	50.82	17.75	17.08	-168.59	21.16	17.33	15.15	20.81	21.15
Last Price	- -	- -	12.9	28.03	11.1	15.15	24.46	23.38	22.8	46.21	28.29	47.47	55	97.28
High Price	- -	- -	13.6	33.25	28	15.75	38.78	29.8	28.43	48.75	55.92	51.04	57.95	98.53
Enterprise Value Average	-1	-2	68	216	162	88	203	223	228	330	401	488	536	790
Enterprise Value High	-1	-2	109	346	285	149	389	296	297	542	647	596	682	1,202
Enterprise Value Low	-1	-2	45	121	79	65	107	148	127	208	271	304	457	553

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	10	10	11	11	11	11	11	12	12	13	13	13	13	13
Diluted Weighted Avg Shares	10	10	10	13	12	12	12	12	12	13	13	13	13	13
Basic Weighted Avg Shares	10	10	9	11	11	11	11	11	12	12	13	13	13	13
Revenue per Share	0.74	1.09	1.79	2.87	3	2.17	2.83	3.41	2.62	3.39	4.24	5.2	5.78	6.59
EBITDA per Share	0.15	0.28	0.37	1.12	1.1	0.24	0.66	0.88	0.05	0.91	1.3	1.65	1.8	2.15
Operating Income per Share	0.14	0.27	0.35	1.05	1.01	0.12	0.56	0.77	-0.06	0.8	1.24	1.59	1.73	2.06
Basic EPS, GAAP	0.09	0.19	0.23	0.68	0.67	0.05	0.59	0.85	0.11	0.76	1.02	1.36	1.52	1.77
Basic EPS from Cont Ops	0.09	0.19	0.23	0.68	0.67	0.05	0.59	0.85	0.11	0.76	1.02	1.36	1.52	1.77
Diluted EPS, GAAP	0.09	0.19	0.2	0.6	0.6	0.04	0.52	0.78	0.11	0.74	1.02	1.35	1.5	1.75
Diluted EPS from Cont Ops	0.09	0.19	0.2	0.6	0.6	0.04	0.52	0.78	0.11	0.74	1.02	1.35	1.5	1.75
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	1.05	1.08	1.18
Cash Flow per Share	0.14	0.14	0.3	0.7	0.87	0.32	0.69	0.91	0.48	0.91	0.8	1.07	2.02	1.96
Free Cash Flow per Basic Share	0.13	0.12	0.23	0.67	0.73	0.24	0.66	0.86	0.44	0.87	0.73	0.48	1.39	1.35
Cash & Equivalents per Share	0.19	0.26	1.99	2.45	2.37	2.48	3.2	4.1	4.29	5.06	4.61	3.95	4.12	4.02
Book Value per Share	0.11	0.3	0.59	1.15	1.84	1.91	2.48	3.22	3.11	3.81	3.76	3.43	4.48	5.05
Tangible Book Value per Share	0.28	0.49	2.36	2.88	2.86	3.01	3.82	4.85	4.98	5.76	5.7	5.47	6.61	7.17

IRadimed Corporation

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)